Majos, A.; Sewerynek, E.; Grząsiak, O.; Ciesielski, W.; Hogendorf, P.; Hołyński, J.; Strzelczyk, J.; Durczyński, A.
FT3 to FT4 Conversion Ratio May Be an Independent Prognostic Factor in Pancreatic Cancer Patients. Biomedicines 2023, 11, 77.
https://doi.org/10.3390/biomedicines11010077
AMA Style
Majos A, Sewerynek E, Grząsiak O, Ciesielski W, Hogendorf P, Hołyński J, Strzelczyk J, Durczyński A.
FT3 to FT4 Conversion Ratio May Be an Independent Prognostic Factor in Pancreatic Cancer Patients. Biomedicines. 2023; 11(1):77.
https://doi.org/10.3390/biomedicines11010077
Chicago/Turabian Style
Majos, Alicja, Ewa Sewerynek, Oliwia Grząsiak, Wojciech Ciesielski, Piotr Hogendorf, Jarosław Hołyński, Janusz Strzelczyk, and Adam Durczyński.
2023. "FT3 to FT4 Conversion Ratio May Be an Independent Prognostic Factor in Pancreatic Cancer Patients" Biomedicines 11, no. 1: 77.
https://doi.org/10.3390/biomedicines11010077
APA Style
Majos, A., Sewerynek, E., Grząsiak, O., Ciesielski, W., Hogendorf, P., Hołyński, J., Strzelczyk, J., & Durczyński, A.
(2023). FT3 to FT4 Conversion Ratio May Be an Independent Prognostic Factor in Pancreatic Cancer Patients. Biomedicines, 11(1), 77.
https://doi.org/10.3390/biomedicines11010077